ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

33,260Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 1121

$1.43M Total Retail Price of All Prescriptions

Rank: 19 out of 1121

849 Patients Receiving at Least One Drug in Part D
41%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

35% of this provider’s 849 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

55% of this provider’s 849 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

5% of this provider’s 14,026 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
HYDROCODONE-ACETAMINOPHEN 3,942 1,524 S3 1 3
LISINOPRIL 1,166 427 2 4
METFORMIN HCL 981 415 3 8
OXYCODONE HCL-ACETAMINOPHEN 961 219 S2 4 86
ZOLPIDEM TARTRATE 944 359 5 19
AMLODIPINE BESYLATE 931 396 6 5
SIMVASTATIN 931 556 6 1
MORPHINE SULFATE ER 836 226 S2 8 87
FUROSEMIDE 776 481 9 7
OMEPRAZOLE 712 257 10 6
HYDROCHLOROTHIAZIDE 601 223 11 10
OXYCODONE HCL 573 143 S2 12 68
PROMETHAZINE HCL 572 141 R 13 67
CARISOPRODOL 509 66 R 14 72
PROAIR HFA 503 180 15 48
KLOR-CON 10 498 278 10 16 69
METOPROLOL TARTRATE 487 226 17 9
POTASSIUM CHLORIDE 465 225 18 12
LEVOTHYROXINE SODIUM 440 247 19 2
NEXIUM 391 138 20 24
SPIRIVA 381 185 21 49
CYCLOBENZAPRINE HCL 370 110 R 22 83
GABAPENTIN 368 135 23 13
AMOX TR-POTASSIUM CLAVULANATE 304 109 24 101
VENTOLIN HFA 286 97 25 92
CARVEDILOL 277 170 26 20
RANITIDINE HCL 268 174 27 33
CLONIDINE HCL 242 67 28 39
BENAZEPRIL HCL 235 118 29 41
FAMOTIDINE 232 96 30 63
CRESTOR 226 98 31 28
CLOPIDOGREL 224 118 32 27
ATENOLOL 218 58 33 16
AMLODIPINE BESYLATE-BENAZEPRIL 214 105 34 65
ENDOCET 212 71 S2 35 107
INSULIN SYRINGE 188 83 36 77
GLIPIZIDE 185 102 37 84
PLAVIX 177 107 38 42
TRAMADOL HCL 176 98 39 25
ENALAPRIL MALEATE 172 143 40 73
TAMSULOSIN HCL 172 159 40 32
AZITHROMYCIN 169 60 42 44
MELOXICAM 169 69 42 22
SERTRALINE HCL 167 41 44 21
PRAVASTATIN SODIUM 162 74 45 14
LOSARTAN POTASSIUM 162 83 45 17
CEPHALEXIN 147 40 47 111
ESTRADIOL 144 47 R 48 95
METHYLPREDNISOLONE 142 49 49 97
WARFARIN SODIUM 139 50 50 11
CITALOPRAM HBR 138 50 51 18
DIOVAN 131 83 52 45
LOVASTATIN 127 35 53 26
IBUPROFEN 120 29 54 110
AMOXICILLIN 119 48 55 140
FLUCONAZOLE 117 40 56 156
INDOMETHACIN 117 35 R 56 287
DIOVAN HCT 116 67 58 90
PREMARIN 115 60 R 59 96
POLYETHYLENE GLYCOL 3350 113 55 60 70
ADVAIR DISKUS 112 49 61 64
LOSARTAN-HYDROCHLOROTHIAZIDE 110 44 62 46
ALLOPURINOL 109 64 63 30
SINGULAIR 108 46 64 78
SYMBICORT 106 59 65 148
TIZANIDINE HCL 101 34 66 124
PEN NEEDLE 101 43 66 137
CYMBALTA 100 32 68 50
LISINOPRIL-HYDROCHLOROTHIAZIDE 99 34 69 31
LANTUS 98 40 70 52
ATORVASTATIN CALCIUM 98 49 70 15
DEXILANT 97 24 72 136
PHENYTOIN SODIUM EXTENDED 96 18 73 135
GLYBURIDE 90 64 R 74 51
HYDROXYZINE HCL 86 43 R 75 168
GLIMEPIRIDE 85 32 76 34
FENTANYL 84 35 S2 77 100
NOVOLOG 82 25 78 139
PANTOPRAZOLE SODIUM 80 30 79 29
KLOR-CON M20 79 20 80 85
AMITRIPTYLINE HCL 75 20 R 81 61
HUMALOG 73 26 82 150
NIFEDIPINE ER 73 64 82 102
ETODOLAC 73 41 82 211
OPANA ER 72 0 S2 85 213
LIDOCAINE HCL 72 50 85 237
LEVETIRACETAM 71 23 87 125
LYRICA 71 15 87 76
DOXYCYCLINE HYCLATE 70 22 89 103
CIPROFLOXACIN HCL 70 21 89 57
METHOCARBAMOL 69 26 R 91 159
PREDNISONE 69 60 91 43
MECLIZINE HCL 69 48 91 115
SULFAMETHOXAZOLE-TRIMETHOPRIM 67 33 94 108
VERAPAMIL ER 67 55 94 89
PAROXETINE HCL 66 25 96 58
RAMIPRIL 65 25 97 74
TRIAMTERENE-HYDROCHLOROTHIAZID 65 52 97 154
HUMALOG MIX 75-25 65 40 97 298
THEOPHYLLINE ANHYDROUS 63 46 100 175
BUMETANIDE 63 33 100 152
DIGOXIN 62 46 102 59
NAPROXEN 62 34 102 116
FLUTICASONE PROPIONATE 61 24 104 36
CEFUROXIME 60 26 105 163
METOCLOPRAMIDE HCL 59 20 106 120
TEKTURNA 59 30 106 276
BETAMETHASONE VALERATE 58 30 108 393
EXFORGE 58 46 108 190
MEGESTROL ACETATE 58 38 R 108 185
TRAZODONE HCL 57 19 111 40
LUNESTA 57 0 111 288
BACLOFEN 57 19 111 131
CARTIA XT 56 29 114 267
ONDANSETRON HCL 55 15 115 234
METOPROLOL SUCCINATE 54 36 116 23
SPIRONOLACTONE 53 35 117 54
MONTELUKAST SODIUM 53 12 117 144
ALCOHOL SWABS 52 13 119 472
KLOR-CON M10 50 36 120 171
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 26, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.